State-of-the-art facilities

Scale up seamlessly with integrated RNA therapeutics CDMO solutions

Axolabs CDMO platform encompasses early-stage discovery to commercial GMP production. Working in concert with our CRO team, we ensure data-driven decisions and a smooth transition from discovery through to clinical development and commercial success.

AxoLabs_AndyBate_0021-scaled
Services CDMO

Early-stage synthesis & lead optimisation

We rapidly produce and optimise siRNAs, ASOs, aptamers, and gRNAs in 96-well plate formats. On-resin and post-synthetic conjugation (e.g. GalNAc, peptides, lipids) enables precise modifications.

Highlights
  • Automated purification (AEX, RP, SEC) for consistent yield.
  • Customisable supports for unique conjugations.
AxoLabs_AndyBate_0011-scaled
AxoLabs_AndyBate_0158-scaled
Services CDMO

Large-scale chemical manufacturing

Using OligoPilot™ (pilot) and OligoProcess™ AK Bio system (commercial), we scale from milligram batches to tens of kilograms under QbD/DoE-driven optimisation.

Highlights
  • Scalable workflows for GLP-tox, clinical, and commercial needs.
  • Real-time process monitoring (UV, LC-MS) ensures quality.
AxoLabs_AndyBate_0017-scaled
AxoLabs_AndyBate_0009-scaled
Services CDMO

cGMP production

Our Petaluma (USA) and Berlin (Germany) sites offer redundant cGMP suites for secure global supply. Production scales cover early-phase through commercial volumes.

Highlights
  • Petaluma: up to 300 mmol batch capacity.
  • Berlin: pilot runs up to 10 kg per batch.
AxoLabs_AndyBate_0004-scaled
AxoLabs_AndyBate_0009-scaled
Services CDMO

GMP analytics & quality control

We provide GMP-aligned analytical development, validation, and stability programmes, meeting EMA/FDA/ICH guidelines.

Highlights
  • High-resolution LC-MS/MS, uHPLC, FT-IR, and CE.
  • Forced degradation and real-time data ensure robust release specs.
AxoLabs_AndyBate_0235-scaled
AxoLabs_AndyBate_0237-scaled
Services CDMO

Integrated technology transfer

Unified QA oversight and project management bridge discovery data with commercial-scale requirements, minimising rework.

Highlights
  • Centralised documentation accelerates validation.
  • Smooth transition from early development to market launch.
AxoLabs_AndyBate_0175-1-scaled
AxoLabs_AndyBate_0006-1-scaled
Services CDMO

Download services list

Axolabs CDMO platform encompasses early-stage discovery to commercial GMP production. Working in concert with our CRO team, we ensure data-driven decisions and a smooth transition from discovery through to clinical development and commercial success.

Contact us

Find out more

Partner with a global leader in oligonucleotide research, development, and manufacturing. Whether you need early-stage optimisation, large-scale GMP production, or specialised analytical support, Axolabs’ experts are ready to help. Get in touch to discuss your project, request a capabilities overview, or schedule a technical consultation.

Find out more